Arterra Bioscience

Milan Stock Exchange ARBS.MI

Arterra Bioscience EBT Margin for the year ending December 31, 2023: 39.03%

Arterra Bioscience EBT Margin is 39.03% for the year ending December 31, 2023, a -22.62% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Arterra Bioscience EBT Margin for the year ending December 31, 2022 was 50.44%, a 51.77% change year over year.
  • Arterra Bioscience EBT Margin for the year ending December 31, 2021 was 33.23%, a -21.02% change year over year.
  • Arterra Bioscience EBT Margin for the year ending December 31, 2020 was 42.08%, a 22.83% change year over year.
  • Arterra Bioscience EBT Margin for the year ending December 31, 2019 was 34.25%, a -21.64% change year over year.
Key data
Date EBT Margin Net Income Margin EBITDA Margin EBIT Margin
Market news
SV Wall Street
Milan Stock Exchange: ARBS.MI

Arterra Bioscience

CEO Ms. Maria Gabriella Colucci
IPO Date Oct. 28, 2019
Location Italy
Headquarters via Benedetto Brin, 69 Napoli, 80142Italy
Employees 34
Sector Healthcare
Industries
Biotechnology Biofuel Bread & Bakery Chemicals & Advanced Materials Cosmetics Personal Care Pharmaceuticals Plastics
Description

Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. It develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Naples, Italy.

StockViz Staff

February 7, 2025

Any question? Send us an email